328130 — Lunit Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for Lunit, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,430	6,639	13,866	25,080	54,180
Cost of Revenue
Gross Profit	1,374	5,878	13,707	24,967	53,914
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	22,381	52,339	64,517	67,296	121,852
Operating Profit	-20,951	-45,700	-50,651	-42,215	-67,673
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-83,739	-73,676	-39,118	-36,764	-83,227
Provision for Income Taxes
Net Income After Taxes	-83,739	-73,676	-39,118	-36,798	-82,421
Net Income Before Extraordinary Items
Net Income	-83,739	-73,676	-39,118	-36,798	-82,421
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-83,739	-73,676	-39,118	-36,798	-82,421
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3,721	-3,274	-1,751	-1,431	-2,857
Dividends per Share